SPYRE THERAPEUTICS, INC.: capex
| Value | {"amount": 208000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2015-01-01 – 2015-12-31 |
| Status | current |
| Entity | SPYRE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:49:35.081957+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a805afc4-b2c2-46f0-99bc-730de2e9b3ba
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-17-005137 · Open the official SEC filing →Retrieved: 2026-08-19T16:49:35.081957+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001636282/capex/2015-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a805afc4-b2c2-46f0-99bc-730de2e9b3ba
History
- no predecessors — first report